Summary
Updated Aug 30, 2026
Namrata Saroj is Chief Business Officer of OCULAR THERAPEUTIX, INC (OCUL). 1 SEC Form 4 filing on record, dated 7 November 2025. Most recent open-market trade: sold $278K of OCUL on 7 November 2025. Lifetime open-market sales: $278K.
Recent Transactions
1Every recent SEC Form 4 transaction Namrata Saroj has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Namrata Saroj files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Pravin Dugel - $1.94M of OCUL open-market activity in the last 12 months
- Richard L. Md Lindstrom - $461K of OCUL open-market activity in the last 12 months
- Jeffrey S. Heier - $243K of OCUL open-market activity in the last 12 months
- Peter Kaiser - $223K of OCUL open-market activity in the last 12 months
- Nadia Waheed - $221K of OCUL open-market activity in the last 12 months
- Donald Notman - $218K of OCUL open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Namrata Saroj?
Namrata Saroj is a corporate insider, tracked as Chief Business Officer of OCULAR THERAPEUTIX, INC (OCUL). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Namrata Saroj last file a Form 4?
The only primary Form 4 on record is dated 7 November 2025.
Has Namrata Saroj been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($278K) across all tracked filings.
Where can I see all of Namrata Saroj's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Namrata Saroj and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
